Revolutionizing Patient Access: Disrupting the Delivery of Cell and Gene Therapies
Wednesday, May 29, 2024 08:00 AM - 09:00 AM
Room 217-219
Roundtable
Organized by: ISCT Industry Committee
Moderator(s)
Panelists
Debate the merits and disadvantages of centralized manufacturing, regional processing, and point of care manufacturing.
Key Learning Objectives
1. What are the issues regarding patient access to CAR-T therapies
2. What are the various scenarios that are being explored
3. Where should therapeutic and tool developers focus their efforts in this space
Moderator(s)
- Julie Allickson, Ph.D, Mayo Clinic Center for Regenerative Biotherapeutics & Biomanufacturing and Product Development, Center for Regenerative Biotherapeutics and Associate Professor of Regenerative Medicine., United States
Panelists
- Boro Dropulic, PhD, Caring Cross, United States
- Jennifer Chow, Chimeric Therapeutics, United States
- Kimberly Schultz, PhD, Food and Drug Administration (FDA), United States
Debate the merits and disadvantages of centralized manufacturing, regional processing, and point of care manufacturing.
Key Learning Objectives
1. What are the issues regarding patient access to CAR-T therapies
2. What are the various scenarios that are being explored
3. Where should therapeutic and tool developers focus their efforts in this space
Julie Allickson
Director of Mayo Clinic's Center for Regenerative Biotherapeutics
Mayo Clinic
Moderator
Director of Mayo Clinic's Center for Regenerative Biotherapeutics
Mayo Clinic
Moderator